Immunomodulatory effects of carbon nanotubes functionalized with a Toll-like receptor 7 agonist on human dendritic cells

Carbon

Volumn 67, Issue , 2014, Pages 273-287

  Ĉolić, Miodrag ^a,b   Dẑopalić, Tanja ^a,b   Tomić, Sergej ^a   Rajković, Jelena ^b   Rudolf, Rebeka ^c   Vuković, Goran ^d   Marinković, Aleksandar ^d   Uskoković, Petar ^d  

^a Serbia   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

^c UNIVERSITY OF MARIBOR   (Slovenia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BIOCOMPATIBILITY; CARBON; CARBON NANOTUBES; CELLS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INTERFERONS; LIGHT TRANSMISSION; NANOTUBES; TRANSMISSION ELECTRON MICROSCOPY; VACCINES; YARN;

CANCER VACCINE; DENDRITIC CELLS (DCS); FUNCTIONALIZED MWCNTS; HUMAN DENDRITIC CELLS; HUMAN MONOCYTES; IMMUNOMODULATORY EFFECTS; INTRACELLULAR CONCENTRATION; TOLL-LIKE RECEPTORS;

MULTIWALLED CARBON NANOTUBES (MWCN);

EID: 84892785218     PISSN: 00086223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbon.2013.09.090     Document Type: Article

References (68)

1. Schnorr JM, Swager TM. Emerging applications of carbon nanotubes. Chem Mater 2011; 23:646-57.
2. Laverny G, Casset A, Purohit A, Schaeffer E, Spiegelhalter C, de Blay F, et al. Immunomodulatory properties of multiwalled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients. Toxicol Lett 2013; 217:91-101.
3. Tkach AV, Shurin GV, Shurin MR, Kisin ER, Murray AR, Young SH, et al. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano 2011; 5:5755-62.
4. Wu HC, Chang XL, Liu L, Zhao F, Zhao YL. Chemistry of carbon nanotubes in biomedical applications. J Mater Chem 2010; 20:1036-52.
5. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007; 2: 469-78.
6. Li R, Wang X, Ji Z, Sun B, Zhang H, Chang CH, et al. Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. ACS Nano 2013; 7 (3): 2352-68.
7. Pescatori M, Bedognetti D, Venturelli E, Ménard-Moyon C, Bernardini C, Muresu E, et al. Functionalized carbon nanotubes as immunomodulator systems. Biomaterials 2013; 34:4395-403.
8. Delogu LG, Venturelli E, Manetti R, Pinna GA, Carru C, Madeddu R, et al. Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine (Lond) 2012; 7:231-43.
9. Dumortier H, Lacotte S, Pastorin G, Marega R, Wu W, Bonifazi D, et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett 2006; 6 (7): 1522-8.
10. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
11. Palomaki J, Karisola P, Pylkkanen L, Savolainen K, Alenius H. Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells. Toxicology 2010; 267:125-31.
12. Wang J, Sun RH, Zhang N, Nie H, Liu JH, Wang JN, et al. Multiwalled carbon nanotubes do not impair immune functions of dendritic cells. Carbon 2009; 47 (7): 1752-60.
13. Inoue K, Koike E, Yanagisawa R, Hirano S, Nishikawa M, Takano H. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol Appl Pharmacol 2009; 237:306-16.
14. Gilboa E. DC-based cancer vaccines. J Clin Invest 2007; 117 (5): 1195-203.
15. Reis e Sousa C. Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol 2004; 16 (1): 21-5.
16. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 2005; 560:11-8.
17. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303 (5663): 1529-31.
18. Birmachu W, Gleason RM, Bulbulian BJ, Riter CL, Vasilakos JP, Lipson KE, et al. Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists. BMC Immunol 2007; 8:26.
19. Smits EL, Ponsaerts P, Berneman ZN, Van Tendeloo VF. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist 2008; 13 (8): 859-75.
20. Lee J, Chuang TH, Redecke V, She L, Pitha PM, Carson DA, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 2003; 100 (11): 6646-51.
21. Smee DF, Alaghamandan HA, Cottam HB, Sharma BS, Jolley WB, Robins RK. Broad-spectrum in vivo antiviral activity of 7- thia-8-oxoguanosine, a novel immunopotentiating agent. Antimicrob Agents Chemother 1989; 33 (9): 1487-92.
22. Dzopalic T, Dragicevic A, Vasilijic S, Vucevic D, Majstorovic I, BozicB, et al. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability. Int Immunopharmacol 2010; 10 (11): 1428-33.
23. Dzopalic T, Dragicevic A, Bozic B, Rajkovic I, Ĉolić M. Dosedependent response of dendritic cells to 7-thia-8-oxoguanosine and its modulation by polyinosinic:polycytidylic acid. Exp Biol Med (Maywood) 2012; 237 (7): 784-92.
24. Vuković G, Marinković A, Obradović M, Radmilović V,Ĉolić M, Aleksić R, et al. Synthesis, characterization and cytotoxicity of surface amino-functionalized water-dispersible multiwalled carbon nanotubes. Appl Surf Sci 2009; 255 (18): 8067-75.
25. Colic M, Mojsilovic S, Pavlovic B, Vucicevic D, Majstorovic I, Bufan B, et al. Comparison of two different protocols for the induction of maturation of human dendritic cells in vitro. Vojnosanit Pregl 2004; 61 (5): 471-8.
26. Zhu J, Paul WE. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev 2010; 238 (1): 247-62.
27. Vuković GD, Marinković AD, Ĉolić M, Ristić M-D, Aleksić R, Perić-Grujić AA, et al. Removal of cadmium from aqueous solutions by oxidized and ethylenediamine- functionalized multi-walled carbon nanotubes. Chem Eng J 2010; 157 (1): 238-48.
28. Du F, Wu K, Yang Y, Liu L, Gan T, Xie X. Synthesis and electrochemical probing of water-soluble poly (sodium 4- styrenesulfonate-co-acrylic acid)-grafted multiwalled carbon nanotubes. Nanotechnology 2008; 19 (8): 085716.
29. Bonifazi D, Nacci C, Marega R, Campidelli S, Ceballos G, Modesti S, et al. Microscopic and spectroscopic characterization of paintbrush-like single-walled carbon nanotubes. Nano Lett 2006; 6 (7): 1408-14.
30. Kim UJ, Furtado CA, Liu X, Chen G, Eklund PC. Raman and IR spectroscopy of chemically processed single-walled carbon nanotubes. J Am Chem Soc 2005; 127 (44): 15437-45.
31. Wang Y, Iqbal Z, Mitra S. Rapidly functionalized, waterdispersed carbon nanotubes at high concentration. J Am Chem Soc 2006; 128 (1): 95-9.
32. Lacotte S, García A, Décossas M, Al-Jamal WT, Li S, Kostarelos K, et al. Interfacing functionalized carbon nanohorns with primary phagocytic cells. Adv Mater 2008; 20:2421-6.
33. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179 (4): 1109-18.
34. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23 (9): 445-9.
35. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages and dendritic cells. Science 2010; 327 (5966): 656-61.
36. Raffa V, Ciofani G, Nitodas S, Karachalios T, D'Alessandro D, Masini M, et al. Can the properties of carbon nanotubes influence their internalization by living cells? Carbon 2008; 46 (12): 1600-10.
37. Lahoud MH, Ahmet F, Zhang JG, Meuter S, Policheni AN, Kitsoulis S, et al. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc Natl Acad Sci USA 2012; 109 (40): 16270-5.
38. Vuković G, Tomić S, Marinković A, Radmilović V, Uskoković P, et al. The response of peritoneal macrophages to dapsone covalently attached on the surface of carbon nanotubes. Carbon 2010; 48 (11): 3066-78.
39. Lee BL, Moon JE, Shu JH, Yuan L, Newman ZR, Schekman R, et al. UNC93B1 mediates differential trafficking of endosomal TLRs. eLife 2013; 2.
40. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) 2005; 5:571-7.
41. Kam NW, Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 2005; 127 (16): 6021-6.
42. Jin H, Heller DA, Sharma R, Strano MS. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 2009; 3 (1): 149-58.
43. Smart SK, Cassady AI, Lu GQ, Martin DJ. The biocompatibility of carbon nanotubes. Carbon 2006; 44 (6): 1034-47.
44. Grabinski C, Hussain S, Lafdi K, Braydich-Stolle L, Schlager J. Effect of particle dimension on biocompatibility of carbon nanomaterials. Carbon 2007; 45 (14): 2828-35.
45. Cheng C, Muller KH, Koziol KK, Skepper JN, Midgley PA, Welland ME, et al. Toxicity and imaging of multi-walled carbon nanotubes in human macrophage cells. Biomaterials 2009; 30 (25): 4152-60.
46. Pulskamp K, Diabate S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 2007; 168 (1): 58-74.
47. Hirano S, Fujitani Y, Furuyama A, Kanno S. Uptake and cytotoxic effects of multi-walled carbon nanotubes in human bronchial epithelial cells. Toxicol Appl Pharmacol 2010; 249 (1): 8-15.
48. Colic M, Gasic S, Vucevic D, Pavicic L, Popovic P, Jandric D, et al. Modulatory effect of 7-thia-8-oxoguanosine on proliferation of rat thymocytes in vitro stimulated with concanavalin A. Int J Immunopharmacol 2000; 22 (3): 203-12.
49. Jeannin P, Magistrelli G, Aubry JP, Caron G, Gauchat JF, Renno T, et al. Soluble CD86 is a costimulatory molecule for human T lymphocytes. Immunity 2000; 13 (3): 303-12.
50. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392 (6673): 245-52.
51. León B, Lopez-Bravo M, Ardavin C. Monocyte-derived dendritic cells. Semin Immunol 2005; 17:313-8.
52. Larangé A, Antonios D, Pallardy M, Kerdine-Römer S. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J Leukoc Biol 2009; 85 (4): 673-83.
53. Baetz A, Frey M, Heeg K, Dalpke AH. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J Biol Chem 2004; 279 (52): 54708-15.
54. Pilsbury LE, Allen RL, Vordermeier M. Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection. Mediators Inflamm 2010. http://dx.doi.org/10.1155/2010/536478.
55. Rouas R, Lewalle P, El Ouriaghli F, Nowak B, Duvillier H, Martiat P. Poly (I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. Int Immunol 2004; 16 (5): 767-73.
56. Schulz O, Edwards AD, Schito M, Aliberti J, Manickasingham S, Sher A, et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000; 13:453-62.
57. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000; 114 (2): 295-302.
58. Lu X, Bao X, Huang Y, Qu Y, Lu H, Lu Z. Mechanisms of cytotoxicity of nickel ions based on gene expression profiles. Biomaterials 2009; 30 (2): 141-8.
59. McNab FW, Rajsbaum R, Stoye JP, O'Garra A. Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 2011; 23 (1): 46-56.
60. Tripathi P, Aggarwal A. NF-kB transcription factor: a key player in the generation of immune response. Curr Sci India 2006; 90 (4): 519-31.
61. Kojima H, Aizawa Y, Yanai Y, Nagaoka K, Takeuchi M, Ohta T, et al. An essential role for NF-kappa B in IL-18-induced IFNgamma expression in KG-1 cells. J Immunol 1999; 162 (9): 5063-9.
62. Mowen KA, Glimcher LH. Signaling pathways in Th2 development. Immunol Rev 2004; 202:203-22.
63. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, Barillot E, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T (H)-17 responses. Nat Immunol 2008; 9 (6): 650-7.
64. Benwell RK, Lee DR. Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells. Clin Immunol 2010; 134 (2): 178-87.
65. Palucka K, Ueno H, Roberts L, Fay J, Banchereau J. Dendritic cell subsets as vectors and targets for improved cancer therapy. Curr Top Microbiol Immunol 2011; 344:173-92.
66. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferongamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75 (2): 163-89.
67. Kryczek I, Wei S, SzeligaW, Vatan L, ZouW. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009; 114 (2): 357-9.
68. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009; 31 (5): 787-98.